JP2005523698A - インフルエンザウイルスの生産用多重プラスミドシステム - Google Patents
インフルエンザウイルスの生産用多重プラスミドシステム Download PDFInfo
- Publication number
- JP2005523698A JP2005523698A JP2003587937A JP2003587937A JP2005523698A JP 2005523698 A JP2005523698 A JP 2005523698A JP 2003587937 A JP2003587937 A JP 2003587937A JP 2003587937 A JP2003587937 A JP 2003587937A JP 2005523698 A JP2005523698 A JP 2005523698A
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- virus
- amino acid
- cells
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16141—Use of virus, viral particle or viral elements as a vector
- C12N2760/16143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16241—Use of virus, viral particle or viral elements as a vector
- C12N2760/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16261—Methods of inactivation or attenuation
- C12N2760/16262—Methods of inactivation or attenuation by genetic engineering
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37567502P | 2002-04-26 | 2002-04-26 | |
US39498302P | 2002-07-09 | 2002-07-09 | |
US41057602P | 2002-09-12 | 2002-09-12 | |
US41980202P | 2002-10-18 | 2002-10-18 | |
US42070802P | 2002-10-23 | 2002-10-23 | |
US45769903P | 2003-03-24 | 2003-03-24 | |
US46236103P | 2003-04-10 | 2003-04-10 | |
PCT/US2003/012728 WO2003091401A2 (fr) | 2002-04-26 | 2003-04-25 | Systeme multiplasmide de production de virus influenza |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011103852A Division JP5303603B2 (ja) | 2002-04-26 | 2011-05-06 | インフルエンザウイルスの生産用多重プラスミドシステム |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005523698A true JP2005523698A (ja) | 2005-08-11 |
JP2005523698A5 JP2005523698A5 (fr) | 2006-06-01 |
Family
ID=29273967
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003587937A Withdrawn JP2005523698A (ja) | 2002-04-26 | 2003-04-25 | インフルエンザウイルスの生産用多重プラスミドシステム |
JP2011103852A Expired - Lifetime JP5303603B2 (ja) | 2002-04-26 | 2011-05-06 | インフルエンザウイルスの生産用多重プラスミドシステム |
JP2013089445A Pending JP2013179943A (ja) | 2002-04-26 | 2013-04-22 | インフルエンザウイルスの生産用多重プラスミドシステム |
JP2013131951A Pending JP2013230156A (ja) | 2002-04-26 | 2013-06-24 | インフルエンザウイルスの生産用多重プラスミドシステム |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011103852A Expired - Lifetime JP5303603B2 (ja) | 2002-04-26 | 2011-05-06 | インフルエンザウイルスの生産用多重プラスミドシステム |
JP2013089445A Pending JP2013179943A (ja) | 2002-04-26 | 2013-04-22 | インフルエンザウイルスの生産用多重プラスミドシステム |
JP2013131951A Pending JP2013230156A (ja) | 2002-04-26 | 2013-06-24 | インフルエンザウイルスの生産用多重プラスミドシステム |
Country Status (13)
Country | Link |
---|---|
US (3) | US8012736B2 (fr) |
EP (2) | EP2497826A1 (fr) |
JP (4) | JP2005523698A (fr) |
KR (2) | KR101169468B1 (fr) |
CN (4) | CN1678345B (fr) |
AR (2) | AR039465A1 (fr) |
AU (2) | AU2003231083A1 (fr) |
CA (1) | CA2482946C (fr) |
DK (1) | DK1499348T3 (fr) |
ES (1) | ES2526191T3 (fr) |
HK (1) | HK1082422A1 (fr) |
TW (2) | TWI347363B (fr) |
WO (1) | WO2003091401A2 (fr) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009532352A (ja) * | 2006-03-31 | 2009-09-10 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | ワクチンのための高力価組み換えインフルエンザ・ウィルス |
JP2009534039A (ja) * | 2006-04-19 | 2009-09-24 | メディミューン,エルエルシー | イヌ細胞中でマイナス鎖ウイルスrnaを発現させるための方法および組成物 |
US8278433B2 (en) | 2005-06-21 | 2012-10-02 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
JP2013507952A (ja) * | 2009-10-20 | 2013-03-07 | ノバルティス アーゲー | ウイルスレスキューのための改善された逆遺伝学 |
JP2016185988A (ja) * | 2005-11-01 | 2016-10-27 | ノバルティス アーゲー | β−プロピオラクトン処理による低レベルの残存細胞DNAを含む細胞由来のウイルスワクチン |
US9890363B2 (en) | 2015-07-06 | 2018-02-13 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
US9950057B2 (en) | 2013-07-15 | 2018-04-24 | Wisconsin Alumni Research Foundation (Warf) | High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs |
US10053671B2 (en) | 2014-06-20 | 2018-08-21 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
US10119124B2 (en) | 2007-06-18 | 2018-11-06 | Wisconsin Alumni Research Foundation (Warf) | Influenza M2 protein mutant viruses as live influenza attenuated vaccines |
US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
US10633422B2 (en) | 2015-06-01 | 2020-04-28 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA |
US10808229B2 (en) | 2009-10-26 | 2020-10-20 | Wisconsin Alumni Research Foundation (“WARF”) | High titer recombinant influenza viruses with enhanced replication in vero cells |
US11197925B2 (en) | 2016-02-19 | 2021-12-14 | Wisconsin Alumni Research Foundation (Warf) | Influenza B virus replication for vaccine development |
US11241492B2 (en) | 2019-01-23 | 2022-02-08 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to genes in influenza viruses |
US11390649B2 (en) | 2019-05-01 | 2022-07-19 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
US11807872B2 (en) | 2019-08-27 | 2023-11-07 | Wisconsin Alumni Research Foundation (Warf) | Recombinant influenza viruses with stabilized HA for replication in eggs |
US11851648B2 (en) | 2019-02-08 | 2023-12-26 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152426A (en) * | 2000-04-28 | 2011-07-31 | St Jude Childrens Res Hospital | A DNA transfection system to form an infectious negative-strand RNA virus |
EP2305699B1 (fr) | 2001-06-05 | 2014-08-13 | CureVac GmbH | ARNm stabilisée avec un contenu augmenté en G/C et optimisée pour la translation dans ses zones codées pour la vaccination contre la trypanosomiase, la leishmaniose et la toxoplasmose |
KR101169468B1 (ko) | 2002-04-26 | 2012-08-01 | 메디뮨 엘엘씨 | 인플루엔자 바이러스의 생산을 위한 다중 플라스미드시스템 |
US7465456B2 (en) | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
US20060110406A1 (en) * | 2003-02-25 | 2006-05-25 | Medimmune Vaccines, Inc. | Refrigerator-temperature stable influenza vaccine compositions |
KR101190932B1 (ko) | 2003-02-25 | 2012-10-16 | 메디뮨 엘엘씨 | 인플루엔자 백신 조성물의 제조 방법 |
KR20060026854A (ko) * | 2003-05-28 | 2006-03-24 | 위스콘신 얼럼나이 리서어치 화운데이션 | PolⅡ 프로모터 및 리보자임을 갖는 재조합 인플루엔자벡터 |
WO2005018539A2 (fr) * | 2003-06-16 | 2005-03-03 | Medimmune Vaccines, Inc. | Hemagglutinine du virus de la grippe et variantes de la neuraminidase |
CA2551489C (fr) | 2003-12-23 | 2013-09-03 | Gregory Duke | Systeme a plasmides multiples pour la production du virus de la grippe |
EP1748790B1 (fr) * | 2004-05-24 | 2015-07-15 | MedImmune, LLC | Systeme multiplasmide pour la production d'un virus grippal |
CA2879182C (fr) * | 2004-05-25 | 2017-02-14 | Medimmune, Inc. | Variantes hemagglutinine et neuraminidase de la grippe |
EP1797189A4 (fr) * | 2004-09-02 | 2010-05-19 | Qun Chen | Systeme d'encapsidation pour la production de particules de types virus de recombinaison |
ES2386272T3 (es) * | 2004-09-09 | 2012-08-16 | Novartis Vaccines And Diagnostics Gmbh | Reducción de riesgos iatrogénicos potenciales asociados a las vacunas antigripales |
NZ555118A (en) | 2004-11-11 | 2009-09-25 | Solvay Biologicals Bv | Defective influenza virus particles incapable of producing functional polymerase |
KR20070086344A (ko) | 2004-11-19 | 2007-08-27 | 위스콘신 얼럼나이 리서어치 화운데이션 | 탠덤 전사 유닛을 갖는 재조합 인플루엔자 벡터 |
EP2573186A1 (fr) | 2004-12-08 | 2013-03-27 | MedImmune, LLC | Procédés de production de compositions de vaccin contre la grippe |
ATE547511T1 (de) | 2004-12-23 | 2012-03-15 | Medimmune Llc | Nichttumorbildende mdck-zellinie zur vermehrung von viren |
BRPI0518568A2 (pt) * | 2004-12-24 | 2008-11-25 | Solvay Pharm Bv | mÉtodo para produzir uma partÍcula do vÍrus da influenza replicativo sem o uso de vÍrus auxiliar, partÍcula de vÍrus da influenza replicativo, cÉlula, composiÇço, uso de uma composiÇço, mÉtodo para gerar proteÇço imunolàgica contra infecÇço de um indivÍduo com um vÍrus da influenza, e, Ácido nuclÉico |
EP1856271A4 (fr) | 2005-03-08 | 2009-11-18 | Medimmune Vaccines Inc | Variants d'hemagglutinine et de neuraminidase du virus influenza |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7959929B2 (en) * | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
JP5349049B2 (ja) | 2005-10-17 | 2013-11-20 | メディミューン,エルエルシー | インフルエンザウイルス製造用マルチプラスミド系 |
US20070197460A1 (en) * | 2005-11-01 | 2007-08-23 | Alnylam Pharmaceuticals, Inc. | Rnai inhibition of influenza virus replication |
US9072701B2 (en) | 2006-04-21 | 2015-07-07 | St. Jude Children's Research Hospital | Avian influenza viruses, vaccines, compositions, formulations, and methods |
US7507411B2 (en) * | 2006-06-23 | 2009-03-24 | University Of Saskatchewan | Attenuated influenza NS1 variants |
EP2049662A4 (fr) * | 2006-07-21 | 2009-12-30 | Medimmune Llc | Procédés et compositions permettant d'accroître la capacité de réplication d'un virus de la grippe |
CN101983069B (zh) * | 2006-08-09 | 2014-07-16 | 米迪缪尼有限公司 | 流感血凝素和神经氨酸酶变体 |
EP2615167A1 (fr) | 2006-09-15 | 2013-07-17 | MedImmune, LLC | Méthode d'élimination de contaminants d'ADN des préparations de virus |
CA2690196A1 (fr) * | 2007-06-18 | 2008-12-24 | Medimmune, Llc | Virus b de la grippe presentant des modifications du polypeptide de l'hemagglutinine |
EP2045323A1 (fr) * | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Constructions linéaires d'expression pour la production de particules de virus influenza |
AU2008331673B2 (en) * | 2007-11-12 | 2014-12-11 | The Trustees Of The University Of Pennsylvania | Novel vaccines against multiple subtypes of influenza virus |
RU2523587C2 (ru) * | 2008-07-11 | 2014-07-20 | МЕДИММЬЮН, ЭлЭлСи | Варианты гемагглютинина и нейрамидазы вируса гриппа |
CN102215865B (zh) | 2008-09-24 | 2013-10-30 | 米迪缪尼有限公司 | 病毒纯化方法 |
WO2010046335A1 (fr) * | 2008-10-21 | 2010-04-29 | Crucell Holland B.V. | Production du virus influenza par génétique inverse dans les cellules per.c6 en conditions asériques |
EP2376628B1 (fr) | 2008-12-16 | 2018-05-16 | Ology Bioservices, Inc. | Production de vaccins contre le virus de la grippe |
EP2233152A1 (fr) | 2009-03-24 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade Ag | Virus de la grippe A réassorti et de croissance haute |
SG2014010185A (en) | 2009-02-12 | 2014-06-27 | Medimmune Llc | Influenza hemagglutinin and neuraminidase variants |
WO2011059285A2 (fr) | 2009-11-16 | 2011-05-19 | (주)지노믹트리 | Méthode de génotypage |
KR101323582B1 (ko) * | 2011-03-17 | 2013-10-30 | 충북대학교 산학협력단 | Vero 세포 유래의 polⅠ 프로모터 및 이를 포함하는 재조합 벡터 |
US20130189303A1 (en) * | 2011-08-02 | 2013-07-25 | Yan Zhou | Recombinant swine influenza virus and uses thereof |
CN102864127A (zh) * | 2011-09-08 | 2013-01-09 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
CN102851258A (zh) * | 2011-09-08 | 2013-01-02 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
CN102864130A (zh) * | 2011-09-08 | 2013-01-09 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
SG11201401137TA (en) | 2011-10-07 | 2014-07-30 | Medimmune Llc | Influenza hemagglutinin variants |
WO2013177595A2 (fr) * | 2012-05-25 | 2013-11-28 | University Of Maryland | Virus de la grippe recombinants et leurs constructions et usages |
KR101443983B1 (ko) * | 2012-12-04 | 2014-11-03 | 충북대학교 산학협력단 | Mdck 세포 특이적으로 증식성이 향상된 다중 돌연변이 인플루엔자 a 바이러스 |
FR3004726A1 (fr) * | 2013-04-18 | 2014-10-24 | Agronomique Inst Nat Rech | Mutants thermosensibles de virus influenza |
CA2918739C (fr) | 2013-07-19 | 2021-09-07 | University Of Rochester | Vaccins attenues contre la grippe et leurs utilisations |
CN104450695B (zh) * | 2014-11-26 | 2017-08-25 | 扬州大学 | A型流感病毒基因pcr扩增引物及其快速克隆方法 |
CN104592367B (zh) * | 2014-12-24 | 2019-01-18 | 中国科学院微生物研究所 | 流感病毒np蛋白突变体及其编码基因与应用 |
WO2016172588A1 (fr) | 2015-04-24 | 2016-10-27 | Andrew Cox | Vaccins atténués contre la grippe et leurs utilisations |
CN111363017B (zh) * | 2018-12-25 | 2022-03-15 | 中国科学院微生物研究所 | A型流感病毒核蛋白s69位突变序列及其突变体与应用 |
WO2020163768A1 (fr) * | 2019-02-07 | 2020-08-13 | Duke University | Virus de la grippe segmentés en 9 et 10 stabilisés en tant que plateforme de vaccin et procédés de fabrication et d'utilisation de ceux-ci |
US11214799B2 (en) * | 2019-03-12 | 2022-01-04 | The University Court Of The University Of Edinburg Old College | HA-specific influenza virus attenuated vaccine comprising mutations in segment 7, and uses therefor |
CN110713988A (zh) * | 2019-05-13 | 2020-01-21 | 广州医科大学附属第一医院(广州呼吸中心) | 一种防止接种于鸡蛋的季节性人流感h3n2病毒抗原性降低的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000060050A2 (fr) * | 1999-04-06 | 2000-10-12 | Wisconsin Alumni Research Foundation | Virus de l'influenza recombinants pour vaccins et traitement genetique |
WO2001083794A2 (fr) * | 2000-04-28 | 2001-11-08 | St. Jude Children's Research Hospital | Systeme de transfection d'adn servant a generer des virus de la grippe infectieuse |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB660109A (en) | 1946-10-01 | 1951-10-31 | American Cyanamid Co | Improvements in or relating to the treatment of allantoic fluid containing a propagated virus together with non-viral proteins to obtain the virus in purified and viable from for use in a vaccine |
US3992522A (en) | 1973-01-24 | 1976-11-16 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Temperature-sensitive recombinant mutant viruses and a process for producing same |
US3874999A (en) | 1973-10-31 | 1975-04-01 | American Cyanamid Co | Process for the purification of virus vaccine |
US4071618A (en) | 1974-09-03 | 1978-01-31 | Research Foundation For Microbial Diseases Of Osaka University | Process for preparing virus disease live vaccines |
US4000257A (en) | 1975-12-22 | 1976-12-28 | American Cyanamid Company | Process for the purification of influenza virus vaccine |
US4057626A (en) | 1976-10-08 | 1977-11-08 | Richardson-Merrell Inc. | Process for detoxifying influenza B virus |
US4338296A (en) | 1979-10-16 | 1982-07-06 | Smithkline-Rit | Influenza virus and process of producing a vaccine therefrom |
US4337242A (en) | 1980-02-05 | 1982-06-29 | Merck & Co., Inc. | Vaccine stabilizer containing L-glutamic acid and L-arginine |
US4512972A (en) | 1980-06-30 | 1985-04-23 | Kureha Chemical Industry Co., Ltd. | Nasal preparation and processes for their production |
JPS57136528A (en) | 1981-02-09 | 1982-08-23 | Hayashibara Biochem Lab Inc | Preparation of viral vaccine |
FR2505657A1 (fr) | 1981-05-13 | 1982-11-19 | Pasteur Institut | Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation |
US4512285A (en) | 1983-12-27 | 1985-04-23 | Gof Manufacturing Company, Inc. | Apparatus and method for egg turning during incubation |
US4634666A (en) | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
GB8914968D0 (en) | 1989-06-29 | 1989-08-23 | Connaught Lab | Production of virus and purification of viral envelope proteins for vaccine use |
US5840520A (en) | 1989-08-28 | 1998-11-24 | Aviron | Recombinant negative strand RNA virus expression systems |
US5166057A (en) | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
US5854037A (en) | 1989-08-28 | 1998-12-29 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
US6887699B1 (en) | 1990-05-22 | 2005-05-03 | Medimmune Vaccines, Inc. | Recombinant negative strand RNA virus expression systems and vaccines |
CA2118234A1 (fr) | 1992-04-14 | 1993-10-28 | Peter Palese | Virus attenues mis au point par genie genetique |
IL105456A (en) | 1992-04-21 | 1996-12-05 | American Home Prod | Vaccines of attenuated respiratory syncytial virus |
CA2075521C (fr) | 1992-05-05 | 1995-11-28 | Kuniaki Koyama | Vaccin vivant stabilise |
ES2210273T5 (es) | 1994-07-18 | 2010-03-29 | Conzelmann, Karl-Klaus, Prof. Dr. | Virus con arn de cadena negativa no segmentado recombinante infeccioso. |
US5824536A (en) | 1994-08-23 | 1998-10-20 | St. Jude Children's Research Hospital | Influenza virus replicated in mammalian cell culture and vaccine production |
US5789229A (en) | 1994-09-30 | 1998-08-04 | Uab Research Foundation | Stranded RNA virus particles |
US5716821A (en) | 1994-09-30 | 1998-02-10 | Uab Research Foundation | Prevention and treatment of respiratory tract disease |
WO1996010633A1 (fr) | 1994-09-30 | 1996-04-11 | Aviron | Virus chimere de la grippe et procede d'electroporation |
US6146873A (en) | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
US5690937A (en) | 1995-06-05 | 1997-11-25 | Aviron | Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene |
DE69510207T3 (de) | 1995-08-09 | 2007-02-15 | Schweiz. Serum- & Impfinstitut Bern | Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren |
AU727923B2 (en) | 1995-09-27 | 2001-01-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
EP0865296B1 (fr) | 1995-10-20 | 2002-02-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Vaccin antigrippe |
EP0864645B9 (fr) | 1995-10-31 | 2006-03-22 | Dnavec Research Inc. | Vecteur de virus a arn a brin negatif possedant une activite de replication autonome |
CA2236378C (fr) | 1995-11-01 | 2011-01-25 | Dnavec Research Inc. | Virus sendai recombinant |
US6090391A (en) | 1996-02-23 | 2000-07-18 | Aviron | Recombinant tryptophan mutants of influenza |
DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
WO1997047738A1 (fr) * | 1996-06-13 | 1997-12-18 | Fujisawa Pharmaceutical Co., Ltd. | Acylase des lipopeptides cycliques |
BRPI9710363B8 (pt) | 1996-07-15 | 2021-07-06 | Us Gov Health & Human Serv | partìcula de vìrus sincicial respirátorio recombinante (rsv) infeccioso atenuado, vacina para induzir proteção contra o vìrus sincicial respiratório recombinante (rsv), vetor de expressão, e, método de produção de um vìrus sincicial respiratório recombinante (rsv) infeccioso. |
AU4427897A (en) | 1996-09-27 | 1998-04-17 | American Cyanamid Company | 3' genomic promoter region and polymerase gene mutations responsible for att enuation in viruses of the order designated mononegavirales |
KR100702523B1 (ko) | 1997-05-23 | 2007-04-04 | 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 | 클로닝된 뉴클레오타이드 서열로부터 약독화된파라인플루엔자 바이러스를 제조하는 방법 |
DE69837764T2 (de) | 1997-07-11 | 2008-01-31 | Yale University, New Haven | Rhabdovirus mit gentechnisch veränderter hülle |
KR20010030630A (ko) | 1997-09-19 | 2001-04-16 | 윌리암 에이취 캘넌, 에곤 이 버그 | 약독화 호흡 신시티아 바이러스 |
US6177082B1 (en) | 1998-08-13 | 2001-01-23 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
US6544785B1 (en) | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
US6146642A (en) | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
WO2000021513A2 (fr) * | 1998-10-09 | 2000-04-20 | Shankar L Sai Latha | Procedes pour traiter la sclerose en plaques |
EP1035209A1 (fr) | 1999-03-06 | 2000-09-13 | ARTEMIS Pharmaceuticals GmbH | Virus influenza recombinants stables dépourvus de virus auxiliaire |
US8715940B2 (en) | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
AU2001250352B2 (en) | 2000-03-02 | 2006-01-12 | Polymun Scientific Immunbiologische Forschung Gmbh | Recombinant influenza a viruses |
KR20030061810A (ko) | 2000-09-25 | 2003-07-22 | 폴리문 사이언티픽 임무노이비오로기쉐 포르슝 게엠베하 | 생균 백신과 제조 방법 |
US7195905B2 (en) | 2001-12-10 | 2007-03-27 | Baxter Healthcare S.A. | Enveloped virus vaccine and method for production |
KR101169468B1 (ko) | 2002-04-26 | 2012-08-01 | 메디뮨 엘엘씨 | 인플루엔자 바이러스의 생산을 위한 다중 플라스미드시스템 |
US7465456B2 (en) * | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
KR101190932B1 (ko) | 2003-02-25 | 2012-10-16 | 메디뮨 엘엘씨 | 인플루엔자 백신 조성물의 제조 방법 |
US20060110406A1 (en) | 2003-02-25 | 2006-05-25 | Medimmune Vaccines, Inc. | Refrigerator-temperature stable influenza vaccine compositions |
WO2005018539A2 (fr) | 2003-06-16 | 2005-03-03 | Medimmune Vaccines, Inc. | Hemagglutinine du virus de la grippe et variantes de la neuraminidase |
US7037707B2 (en) | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
CA2551489C (fr) | 2003-12-23 | 2013-09-03 | Gregory Duke | Systeme a plasmides multiples pour la production du virus de la grippe |
EP1748790B1 (fr) | 2004-05-24 | 2015-07-15 | MedImmune, LLC | Systeme multiplasmide pour la production d'un virus grippal |
WO2006041819A1 (fr) | 2004-10-06 | 2006-04-20 | Medimmune Vaccines, Inc. | Compositions vaccinales antigrippales stables a des temperatures de refrigerateur |
ES2382446T3 (es) | 2004-11-01 | 2012-06-08 | Eiken Kagaku Kabushiki Kaisha | Método de detección del virus de la gripe aviar H5 |
CA2690196A1 (fr) | 2007-06-18 | 2008-12-24 | Medimmune, Llc | Virus b de la grippe presentant des modifications du polypeptide de l'hemagglutinine |
WO2009122431A2 (fr) * | 2008-02-15 | 2009-10-08 | Sun Pharma Advanced Research Company Ltd., | Comprimé oral à libération contrôlée |
-
2003
- 2003-04-25 KR KR20047017199A patent/KR101169468B1/ko active IP Right Grant
- 2003-04-25 US US10/423,828 patent/US8012736B2/en active Active
- 2003-04-25 CN CN038151952A patent/CN1678345B/zh not_active Expired - Fee Related
- 2003-04-25 DK DK03724208.8T patent/DK1499348T3/en active
- 2003-04-25 JP JP2003587937A patent/JP2005523698A/ja not_active Withdrawn
- 2003-04-25 CN CN201310364981.3A patent/CN103540568A/zh active Pending
- 2003-04-25 WO PCT/US2003/012728 patent/WO2003091401A2/fr active Application Filing
- 2003-04-25 AU AU2003231083A patent/AU2003231083A1/en not_active Abandoned
- 2003-04-25 CN CN201310365550.9A patent/CN103540613A/zh active Pending
- 2003-04-25 CA CA 2482946 patent/CA2482946C/fr not_active Expired - Lifetime
- 2003-04-25 EP EP20120168901 patent/EP2497826A1/fr not_active Withdrawn
- 2003-04-25 CN CNA038151952A patent/CN1678345A/zh active Granted
- 2003-04-25 KR KR1020117011414A patent/KR101229202B1/ko active IP Right Grant
- 2003-04-25 ES ES03724208.8T patent/ES2526191T3/es not_active Expired - Lifetime
- 2003-04-25 EP EP03724208.8A patent/EP1499348B1/fr not_active Expired - Lifetime
- 2003-04-28 TW TW099140358A patent/TWI347363B/zh not_active IP Right Cessation
- 2003-04-28 AR ARP030101459 patent/AR039465A1/es active IP Right Grant
- 2003-10-28 TW TW92109896A patent/TWI338047B/zh not_active IP Right Cessation
-
2006
- 2006-03-31 HK HK06104014A patent/HK1082422A1/xx not_active IP Right Cessation
-
2009
- 2009-10-09 AU AU2009225296A patent/AU2009225296B2/en not_active Ceased
-
2011
- 2011-05-06 JP JP2011103852A patent/JP5303603B2/ja not_active Expired - Lifetime
- 2011-06-16 AR ARP110102084 patent/AR081941A2/es unknown
- 2011-08-19 US US13/214,110 patent/US8722059B2/en not_active Expired - Lifetime
-
2013
- 2013-04-22 JP JP2013089445A patent/JP2013179943A/ja active Pending
- 2013-06-24 JP JP2013131951A patent/JP2013230156A/ja active Pending
-
2014
- 2014-03-21 US US14/222,461 patent/US20140220075A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000060050A2 (fr) * | 1999-04-06 | 2000-10-12 | Wisconsin Alumni Research Foundation | Virus de l'influenza recombinants pour vaccins et traitement genetique |
WO2001083794A2 (fr) * | 2000-04-28 | 2001-11-08 | St. Jude Children's Research Hospital | Systeme de transfection d'adn servant a generer des virus de la grippe infectieuse |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8742089B2 (en) | 2005-06-21 | 2014-06-03 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
US8278433B2 (en) | 2005-06-21 | 2012-10-02 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
JP7049761B2 (ja) | 2005-11-01 | 2022-04-07 | ノバルティス アーゲー | β-プロピオラクトン処理による低レベルの残存細胞DNAを含む細胞由来のウイルスワクチン |
JP2016185988A (ja) * | 2005-11-01 | 2016-10-27 | ノバルティス アーゲー | β−プロピオラクトン処理による低レベルの残存細胞DNAを含む細胞由来のウイルスワクチン |
US9254318B2 (en) | 2006-03-31 | 2016-02-09 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
JP2014131516A (ja) * | 2006-03-31 | 2014-07-17 | Warf - Wisconsin Alumni Research Foundation | ワクチンのための高力価組み換えインフルエンザ・ウィルス |
JP2016169225A (ja) * | 2006-03-31 | 2016-09-23 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | ワクチンのための高力価組み換えインフルエンザ・ウィルス |
US9926535B2 (en) | 2006-03-31 | 2018-03-27 | Wisconsin Alumni Research Foundation (Warf) | High titer recombinant influenza viruses for vaccines |
JP2009532352A (ja) * | 2006-03-31 | 2009-09-10 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | ワクチンのための高力価組み換えインフルエンザ・ウィルス |
JP2009534039A (ja) * | 2006-04-19 | 2009-09-24 | メディミューン,エルエルシー | イヌ細胞中でマイナス鎖ウイルスrnaを発現させるための方法および組成物 |
US10119124B2 (en) | 2007-06-18 | 2018-11-06 | Wisconsin Alumni Research Foundation (Warf) | Influenza M2 protein mutant viruses as live influenza attenuated vaccines |
JP2013507952A (ja) * | 2009-10-20 | 2013-03-07 | ノバルティス アーゲー | ウイルスレスキューのための改善された逆遺伝学 |
US10808229B2 (en) | 2009-10-26 | 2020-10-20 | Wisconsin Alumni Research Foundation (“WARF”) | High titer recombinant influenza viruses with enhanced replication in vero cells |
US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
US11007262B2 (en) | 2010-03-23 | 2021-05-18 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
US10172934B2 (en) | 2013-07-15 | 2019-01-08 | Wisconsin Alumni Research Foundation (Warf) | High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs |
US9950057B2 (en) | 2013-07-15 | 2018-04-24 | Wisconsin Alumni Research Foundation (Warf) | High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs |
US11046934B2 (en) | 2014-06-20 | 2021-06-29 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
US11802273B2 (en) | 2014-06-20 | 2023-10-31 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
US10053671B2 (en) | 2014-06-20 | 2018-08-21 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
US10633422B2 (en) | 2015-06-01 | 2020-04-28 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA |
US9890363B2 (en) | 2015-07-06 | 2018-02-13 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
US10246686B2 (en) | 2015-07-06 | 2019-04-02 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
US11197925B2 (en) | 2016-02-19 | 2021-12-14 | Wisconsin Alumni Research Foundation (Warf) | Influenza B virus replication for vaccine development |
US11241492B2 (en) | 2019-01-23 | 2022-02-08 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to genes in influenza viruses |
US11851648B2 (en) | 2019-02-08 | 2023-12-26 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
US11390649B2 (en) | 2019-05-01 | 2022-07-19 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
US11807872B2 (en) | 2019-08-27 | 2023-11-07 | Wisconsin Alumni Research Foundation (Warf) | Recombinant influenza viruses with stabilized HA for replication in eggs |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5303603B2 (ja) | インフルエンザウイルスの生産用多重プラスミドシステム | |
JP5264955B2 (ja) | インフルエンザウイルス作製のための多重プラスミド系 | |
US9238825B2 (en) | Multi plasmid system for the production of influenza virus | |
JP5349049B2 (ja) | インフルエンザウイルス製造用マルチプラスミド系 | |
EP1748790B1 (fr) | Systeme multiplasmide pour la production d'un virus grippal | |
JP2009511073A6 (ja) | インフルエンザウイルス製造用マルチプラスミド系 | |
AU2012201931B2 (en) | Multi-plasmid system for the production of influenza virus | |
CA2827114A1 (fr) | Systeme multiplasmide de production de virus influenza | |
AU2014213478A1 (en) | Multi-plasmid system for the production of influenza virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060404 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060404 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090520 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090819 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090827 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090924 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20090924 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091014 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20091014 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091130 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20100830 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20100830 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110104 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110506 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110714 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110721 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20110909 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130104 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130109 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130201 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130207 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130304 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130307 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20130401 |